U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07354308) titled 'Study to Evaluate the Efficacy of an Avocado Dietary Supplement' on Dec. 06, 2025.
Brief Summary: This 16-week, randomized, triple-blinded, placebo-controlled study evaluates the effects of an avocado dietary supplement (Metavo) on healthy weight and blood glucose management in overweight adults. The study includes body measurements, questionnaires, blood tests, and CGM monitoring to assess metabolic outcomes and participant-reported perceptions of well-being.
Study Start Date: May 01, 2025
Study Type: INTERVENTIONAL
Condition:
Overweight
Metabolic Health
Insulin Resistance
Intervention:
DIETARY_SUPPLEMENT: Metavo Supplement
...